3-(2,4-dimethoxybenzylidene)anabaseine and Colitis

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jiang, J; Ma, J; Tang, N; Ye, Z; Zhang, H; Zhao, X; Zhu, Y	1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Colitis

Article	Year
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates DSS-induced intestinal colitis by improving intestinal mucosal barrier function. Molecular medicine (Cambridge, Mass.), 2022, 06-03, Volume: 28, Issue:1 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Pyridines; Tight Junction Proteins	2022

Article

Year

α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates DSS-induced intestinal colitis by improving intestinal mucosal barrier function.

Molecular medicine (Cambridge, Mass.), 2022, 06-03, Volume: 28, Issue:1

Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Pyridines; Tight Junction Proteins

2022